QQ客服 官方微博 反馈留言

	Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes
	Yu Lu[1]; Chen Yuan[2]; Shi Jie[3]; Wang Rufeng[4]; Yang Yingbo[5]; Yang Li[6]; Zhao Shujuan[7]; Wang Zhengtao[8]
刊名	Journal of ginseng research
	2019
卷号	43页码:116-124
关键词	20(R)-ginsenosides UDP-glycosyltransferase biosynthesis ginsenoside
ISSN号	1226-8453
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2164069
专题	上海大学
作者单位	1.[1]School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China. 2.[2]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 3.[3]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 4.[4]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 5.[5]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 6.[6]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 7.[7]Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 8.[8]School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
推荐引用方式 GB/T 7714	Yu Lu[1],Chen Yuan[2],Shi Jie[3],et al. Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes[J]. Journal of ginseng research,2019,43:116-124.
APA	Yu Lu[1].,Chen Yuan[2].,Shi Jie[3].,Wang Rufeng[4].,Yang Yingbo[5].,...&Wang Zhengtao[8].(2019).Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes.Journal of ginseng research,43,116-124.
MLA	Yu Lu[1],et al."Biosynthesis of rare 20(R)-protopanaxadiol/protopanaxatriol type ginsenosides through Escherichia coli engineered with uridine diphosphate glycosyltransferase genes".Journal of ginseng research 43(2019):116-124.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。